KZA 0.00% 8.0¢ kazia therapeutics limited

The 3rd Glioblastoma Drug Development Summit, page-2

  1. 69 Posts.
    lightbulb Created with Sketch. 62
    Phase II study?! With patent protection expiring in 5 years or so, KZA really need to be presenting a Phase III study I would have thought. @harvett @Pbnewby Tagging you here to make sure you're across this.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.